Valuation Telix Pharmaceuticals Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:07 20/05/2026 BST			5-day change	1st Jan Change
14.00 ^AUD	-1.48%		-2.98%	+25.00%

05-15	Telix to Collaborate With EDAP, Profound Medical to Explore PSMA-PET Imaging in Prostate Cancer Therapies	MT
05-15	Telix announces collaborations to explore PSMA-PET imaging in emerging prostate cancer treatment approaches	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	2,209	2,300	3,263	8,238	3,794	4,748	-	-
Change	-	4.1%	41.89%	152.44%	-53.95%	25.14%	-	-
Enterprise Value (EV) ¹	2,187	2,187	3,149	8,098	4,167	5,153	5,191	5,174
Change	-	-0.02%	44.01%	157.15%	-48.55%	23.67%	0.74%	-0.34%
P/E ratio	-27.2x	-21.7x	626x	170x	-375x	794x	88.1x	34.5x
PBR	1,024x	28.7x	21.9x	14.5x	6.43x	8.46x	8.3x	7.68x
PEG	-	-1.2x	-6x	0x	3x	-5x	0x	0x
Capitalization / Revenue	291x	14.4x	6.49x	10.5x	3.17x	3.5x	3x	2.63x
EV / Revenue	288x	13.7x	6.27x	10.3x	3.48x	3.8x	3.28x	2.86x
EV / EBITDA	-31.2x	-32.3x	53.9x	81.6x	74.4x	63.8x	42.4x	24.8x
EV / EBIT	-29.1x	-29.9x	60.9x	88.7x	98.7x	101x	53.8x	27.7x
EV / FCF	-35.2x	-29.9x	223x	282x	-68.4x	440x	67x	26.5x
FCF Yield	-2.84%	-3.35%	0.45%	0.35%	-1.46%	0.23%	1.49%	3.78%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.285	-0.335	0.0161	0.1446	-0.0299	0.0176	0.159	0.4062
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7.596	160.1	502.5	783.2	1,198	1,358	1,581	1,808
EBITDA ¹	-70.07	-67.8	58.44	99.28	55.98	80.76	122.4	208.4
EBIT ¹	-75.25	-73.18	51.69	91.26	42.23	51.18	96.52	186.6
Net income ¹	-80.51	-104.1	5.211	49.92	-10.1	6.642	47.8	126.3
Net Debt ¹	-22.02	-113	-114.1	-139.5	372.9	405.3	443.4	425.9
Reference price ²	7.75	7.27	10.08	24.61	11.20	14.00	14.00	14.00
Nbr of stocks (in thousands)	285,073	316,343	323,727	334,724	338,721	339,114	-	-
Announcement Date	23/02/22	27/02/23	22/02/24	20/02/25	19/02/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TELIX PHARMACEUTICALS LIMITED	805.56x	3.85x	64.69x	-.--%	3.42B
LONZA GROUP AG	29.51x	5.23x	16.21x	1.12%	43.14B
BEONE MEDICINES AG	45x	4.51x	28.77x	-.--%	33.02B
REVOLUTION MEDICINES, INC.	-18.56x	281.56x	-16.75x	-.--%	31.32B
IQVIA HOLDINGS INC.	21.08x	2.48x	10.71x	-.--%	28.9B
CELLTRION, INC.	29.22x	7.55x	19.41x	0.42%	25.34B
EUROFINS SCIENTIFIC SE	21.31x	1.87x	8.24x	1.25%	12.5B
MEDPACE HOLDINGS, INC.	24.65x	3.91x	17.8x	-.--%	11.99B
Average	119.72x	38.87x	18.63x	0.35%	23.7B
Weighted average by Cap.	36.07x	50.30x	12.99x	0.39%